RiboPro Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 10

RiboPro General Information

Description

Developer of ribonucleic acid products designed to be used as research tools and therapeutics. The company uses proprietary technologies including de-immunization of mRNA (messenger ribonucleic acid), expression boosting and prolonging libraries, and novel LNP (lipid nanoparticle) compositions for delivery to a variety of tissues, enabling researchers to seamlessly integrate RNA into their projects while ensuring reliable quality and performance.

Contact Information

Website
www.ribopro.eu
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kloosterstraat 9
  • OP-Building
  • 5349 AB Oss
  • Netherlands
+31 085
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Kloosterstraat 9
  • OP-Building
  • 5349 AB Oss
  • Netherlands
+31 085

RiboPro Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RiboPro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 31-Oct-2024 Completed Generating Revenue
5. Later Stage VC 10-Jan-2024 Completed Generating Revenue
4. Accelerator/Incubator 24-Dec-2021 Completed Generating Revenue
3. Grant 31-Oct-2021 Completed Generating Revenue
2. Seed Round 23-Mar-2021 $1.44M $1.44M Completed Generating Revenue
1. Grant 01-Jun-2020 $21.8K Completed Startup
To view RiboPro’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RiboPro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ribonucleic acid products designed to be used as research tools and therapeutics. The company uses propriet
Biotechnology
Oss, Netherlands
35 As of 2025

San Diego, CA
 

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RiboPro Competitors (2)

One of RiboPro’s 2 competitors is TriLink BioTechnologies, a Private Equity-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TriLink BioTechnologies Private Equity-Backed San Diego, CA
etherna Formerly VC-backed Niel, Belgium
You’re viewing 2 of 2 competitors. Get the full list »

RiboPro Patents

RiboPro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202502932-D0 Rna polymerase Pending 28-Feb-2025
GB-202502936-D0 Rna polymerase Pending 28-Feb-2025
WO-2026180681-A2 Rna polymerase Pending 28-Feb-2025
WO-2026180681-A3 Rna polymerase Pending 28-Feb-2025
WO-2026180687-A1 Rna polymerase Pending 28-Feb-2025 C12Y207/07006
To view RiboPro’s complete patent history, request access »

RiboPro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RiboPro Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mountainview Capital Partners Growth/Expansion Minority
Skirderf Capital Family Office Minority
EchiumBio Holding PE/Buyout Minority
Fredriks family Family Office Minority
Blue Tulip Awards Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

RiboPro FAQs

  • When was RiboPro founded?

    RiboPro was founded in 2020.

  • Where is RiboPro headquartered?

    RiboPro is headquartered in Oss, Netherlands.

  • What is the size of RiboPro?

    RiboPro has 35 total employees.

  • What industry is RiboPro in?

    RiboPro’s primary industry is Biotechnology.

  • Is RiboPro a private or public company?

    RiboPro is a Private company.

  • What is RiboPro’s current revenue?

    The current revenue for RiboPro is .

  • How much funding has RiboPro raised over time?

    RiboPro has raised $3.52M.

  • Who are RiboPro’s investors?

    Mountainview Capital Partners, Skirderf Capital, EchiumBio Holding, Fredriks family, and Blue Tulip Awards are 5 of 10 investors who have invested in RiboPro.

  • Who are RiboPro’s competitors?

    TriLink BioTechnologies and etherna are competitors of RiboPro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process